Pomanda estimates the enterprise value of RENALYTIX PLC at £657.8k based on a Turnover of £1.8m and 0.37x industry multiple (adjusted for size and gross margin).
renalytix plcEstimated Valuation
£0
Pomanda estimates the enterprise value of RENALYTIX PLC at £0 based on an EBITDA of £-22.3m and a 2.5x industry multiple (adjusted for size and gross margin).
renalytix plcEstimated Valuation
£0
Pomanda estimates the enterprise value of RENALYTIX PLC at £0 based on Net Assets of £-7.1m and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Renalytix PlcOverview
Renalytix Plc is a live company located in london, E1W 9US with a Companies House number of 11257655. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in March 2018, it's largest shareholder is
ekf diagnostics holdings plc
with a 100% stake. Renalytix Plc is a young,
small sized company, Pomanda has estimated its turnover at
£1.8m with
rapid
growth in recent years.
Pomanda's financial health check has awarded Renalytix Plc a 1 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 8 areas for improvement. Company Health Check FAQs
Health Rating1out of 5
2 Strong
1 Regular
8 Weak
Size
annual sales of £1.8m, make it in line with the average company (£2.1m)
£1.8m - Renalytix Plc
£2.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 1044%, show it is growing at a faster rate (10%)
1044% - Renalytix Plc
10% - Industry AVG
Production
with a gross margin of 9.3%, this company has a higher cost of product (47.3%)
9.3% - Renalytix Plc
47.3% - Industry AVG
Profitability
an operating margin of -1333.3% make it less profitable than the average company (5.5%)
-1333.3% - Renalytix Plc
5.5% - Industry AVG
Employees
with 60 employees, this is above the industry average (18)
60 - Renalytix Plc
18 - Industry AVG
Pay Structure
on an average salary of £158.4k, the company has a higher pay structure (£51.7k)
£158.4k - Renalytix Plc
£51.7k - Industry AVG
Efficiency
resulting in sales per employee of £30k, this is less efficient (£119.4k)
£30k - Renalytix Plc
£119.4k - Industry AVG
Debtor Days
it gets paid by customers after 115 days, this is later than average (53 days)
115 days - Renalytix Plc
53 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Renalytix Plc
- - Industry AVG
Stock Days
it holds stock equivalent to 47 days, this is more than average (31 days)
47 days - Renalytix Plc
31 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 20 weeks, this is less cash available to meet short term requirements (26 weeks)
20 weeks - Renalytix Plc
26 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 226.6%, this is a higher level of debt than the average (52.6%)
226.6% - Renalytix Plc
52.6% - Industry AVG
RENALYTIX PLC financials
EXPORT
Renalytix Plc's latest turnover from June 2024 is £1.8 million and the company has net assets of -£7.1 million. According to their latest financial statements, Renalytix Plc has 60 employees and maintains cash reserves of £3.7 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Jun 2024
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Jun 2019
Jun 2018
Turnover
1,801,369
2,678,051
2,394
1,202
Other Income Or Grants
Cost Of Sales
1,633,745
2,126,387
1,654
648
Gross Profit
167,624
551,664
740
554
Admin Expenses
24,185,882
33,883,686
46,985
26,840
8,383
5,424,264
418
Operating Profit
-24,018,258
-33,332,022
-46,245
-26,286
-8,383
-5,424,264
-418
Interest Payable
450,146
115,684
138
7,203
2
14,358
Interest Receivable
274,651
516,250
7,905
794
403
27,997
Pre-Tax Profit
-35,783,426
-36,374,439
-40,003
-28,847
-8,029
-5,410,625
-418
Tax
-1,574
-5,726
3,851
1,029
688,442
Profit After Tax
-35,783,426
-36,376,013
-45,729
-24,996
-7,000
-4,722,182
-418
Dividends Paid
-24,996
-7,000
Retained Profit
-35,783,426
-36,376,013
-45,729
-4,722,182
-418
Employee Costs
9,504,210
16,437,397
21,382
10,008
3,510
1,491,744
44,063
Number Of Employees
60
82
93
47
12
5
1
EBITDA*
-22,316,834
-31,381,129
-44,255
-24,673
-8,383
-4,615,937
-418
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2024
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Jun 2019
Jun 2018
Tangible Assets
223,499
848,351
1,457
12,612
5,753
888,011
Intangible Assets
9,998,426
11,301
14,526
12,953
13,127,782
Investments & Other
55,874
40,135
7
1,465
Debtors (Due After 1 year)
60
5,781
1,817
688,442
Total Fixed Assets
223,498
10,846,777
12,757
21,417
16,951
14,015,793
Stock & work in progress
213,268
565,042
935
284
246
Trade Debtors
568,191
610,687
726
479
Group Debtors
13
Misc Debtors
286,456
445,423
928
419
43,790
Cash
3,683,009
19,423,939
33,316
52,522
10,059
6,667,623
82
misc current assets
609,900
1,252,853
2,325
7,562
2,689
35,176
7
total current assets
5,360,825
22,297,946
38,232
61,266
14,299
6,746,590
89
total assets
5,584,323
33,144,723
50,989
82,683
31,250
20,762,383
89
Bank overdraft
Bank loan
Trade Creditors
1,983
1,423
Group/Directors Accounts
44
282
205
other short term finances
3,272,999
3,512,237
42
91
438
hp & lease commitments
36,200
122,766
131
69
69
other current liabilities
5,936,884
9,060,359
7,679
4,037
2,192
541,994
total current liabilities
9,246,085
12,695,365
9,838
5,854
2,560
541,996
438
loans
6,816,714
11,853,308
324
342
618
hp & lease commitments
36,200
162
171
208
Accruals and Deferred Income
other liabilities
6,192
1,168
provisions
total long term liabilities
3,408,357
5,926,654
6,354
171
1,477
total liabilities
12,654,442
18,622,019
16,192
6,025
4,037
541,996
438
net assets
-7,070,119
14,522,704
34,797
76,658
27,213
20,220,387
-349
total shareholders funds
-7,070,119
14,522,704
34,797
76,658
27,213
20,220,388
-349
Jun 2024
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Jun 2019
Jun 2018
Operating Activities
Operating Profit
-24,018,258
-33,332,022
-46,245
-26,286
-8,383
-5,424,264
-418
Depreciation
144,802
394,271
245
111
22,254
Amortisation
1,556,622
1,556,622
1,745
1,502
786,073
Tax
-1,574
-5,726
3,851
1,029
688,442
Stock
-351,774
564,107
651
38
246
Debtors
-201,463
1,054,396
-4,964
4,848
-730,402
732,232
Creditors
-1,983
560
1,423
Accruals and Deferred Income
-3,123,475
9,052,680
3,642
1,845
-539,802
541,994
Deferred Taxes & Provisions
Cash flow from operations
-24,887,072
-23,950,509
-41,466
-22,440
183,000
-4,117,733
-418
Investing Activities
capital expenditure
8,921,854
-12,784,912
12,390
-10,045
13,997,086
-14,824,120
Change in Investments
15,739
40,128
7
-1,465
1,465
cash flow from investments
8,906,115
-12,825,040
12,383
-8,580
13,995,621
-14,824,120
Financing Activities
Bank loans
Group/Directors Accounts
-44
-238
77
205
Other Short Term Loans
-239,238
3,512,237
-42
-49
91
-438
438
Long term loans
-5,036,594
11,852,984
-18
-276
618
Hire Purchase and Lease Commitments
-122,766
158,673
53
-37
277
other long term liabilities
-6,192
6,192
-1,168
1,168
share issue
14,190,603
50,863,920
3,868
49,445
-20,193,175
24,942,919
69
interest
-175,495
400,566
7,767
-6,409
401
13,639
cash flow from financing
8,616,510
66,782,144
17,582
41,583
-20,190,415
24,956,120
507
cash and cash equivalents
cash
-15,740,930
19,390,623
-19,206
42,463
-6,657,564
6,667,541
82
overdraft
change in cash
-15,740,930
19,390,623
-19,206
42,463
-6,657,564
6,667,541
82
renalytix plc Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for renalytix plc. Get real-time insights into renalytix plc's credit score, group structure and payment trends.
Perform a competitor analysis for renalytix plc by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in E1W area or any other competitors across 12 key performance metrics.
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to renalytix plc.
renalytix plc Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for RENALYTIX PLC. This can take several minutes, an email will notify you when this has completed.
renalytix plcCompanies House Filings - See Documents
